Role of Adjuvant Chemotherapy in NSCLC (Stages I to III)
Complete surgical resection is the main therapy for early-stage non-small cell lung cancer. Survival rates remain, at best, 80% for stage IA, necessitating the development of effective systemic therapy. Several…